» Articles » PMID: 7032945

The Tamoxifen Trial - a Double-blind Comparison with Stilboestrol in Postmenopausal Women with Advanced Breast Cancer

Overview
Specialty Oncology
Date 1980 Jan 1
PMID 7032945
Citations 3
Authors
Affiliations
Soon will be listed here.
Citing Articles

Estrogen therapy induces an unfolded protein response to drive cell death in ER+ breast cancer.

Hosford S, Shee K, Wells J, Traphagen N, Fields J, Hampsch R Mol Oncol. 2019; 13(8):1778-1794.

PMID: 31180176 PMC: 6670014. DOI: 10.1002/1878-0261.12528.


Estrogen as therapy for breast cancer.

Ingle J Breast Cancer Res. 2002; 4(4):133-6.

PMID: 12100736 PMC: 138731. DOI: 10.1186/bcr436.


On the role of additive hormone monotherapy with tamoxifen, medroxyprogesterone acetate and aminoglutethimide, in advanced breast cancer.

Petru E, Schmahl D Klin Wochenschr. 1987; 65(20):959-66.

PMID: 2963170 DOI: 10.1007/BF01717830.